Advertisement
Screener

VYOME HOLDINGS, INC. (HIND) Price / Book

2.8 / 5 stars · 68/120 Roast Me

Vyome Holdings, Inc Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

  • Vyome Holdings, Inc price/book ratio for the quarter ending 2025-09-30 was 5.48, a 97.95% decline year-over-year.
  • Vyome Holdings, Inc price/book ratio for the quarter ending 2025-06-30 was 4.39, a 99.96% decline year-over-year.
  • Vyome Holdings, Inc price/book ratio for the quarter ending 2025-03-31 was 3.91, a 99.93% decline year-over-year.
  • Vyome Holdings, Inc price/book ratio for the quarter ending 2024-09-30 was 267.76, a 87.80% decline year-over-year.
  • Vyome Holdings, Inc price/book ratio for fiscal 2025 was 5.48, a 97.95% decline from fiscal 2024.
  • Vyome Holdings, Inc price/book ratio for fiscal 2024 was 267.76.
  • Vyome Holdings, Inc price/book ratio for fiscal 2023 was 88.01, a 98.41% decline from fiscal 2022.
  • Vyome Holdings, Inc price/book ratio for fiscal 2022 was 5,544.2, a 44.91% increase from fiscal 2021.
Available history
2016-12-31 to 2025-09-30
Data captured

Historical Price/Book Ratio

DatePrice/Book RatioMarket capitalizationShareholder equity
2025-09-305.48$13.87M$2.53M
2025-06-304.39$25.61M$5.83M
2025-03-313.91$4.8M$1.23M
2024-09-30267.76$398.15M$1.49M
2024-06-3010,782.7$32.73B$3.04M
2024-03-315,521.26$25.03B$4.53M
2023-12-3188.01$586.43M$6.66M
2023-09-302,195.57$6.77B$3.08M
2023-06-304,397.95$29.63B$6.74M
2023-03-315,089.26$39.48B$7.76M
2022-12-315,544.2$20.3B$3.66M
2022-09-30103,721.31$1.97T$18.95M
2022-06-30106,727.29$3.28T$30.78M
2022-03-31172,192.75$6.36T$36.96M
2021-12-313,825.92$169.62B$44.33M
2021-09-30186,268.08$14.77T$79.31M
2021-06-30203,751.84$11.84T$58.13M
2021-03-311,934,758.81$24.59T$12.71M
2020-12-31314,022.65$4.55T$14.49M
2020-09-30360,127.71$6.15T$17.08M
2020-06-30247,946.72$4.75T$19.15M
2020-03-31224,550.02$4.84T$21.57M
2019-12-31529,636.09$12.77T$24.11M
2019-09-30649,725.19$13.04T$20.07M
2019-06-3025,834,354.17$216.39T$8.38M
2019-03-3146,608,999.75$303.8T$6.52M
2018-12-313,230,728.31$42.35T$13.11M
2018-09-3027,135,140.27$546.85T$20.15M
2018-06-3020,811,604.16$334.05T$16.05M
2018-03-3121,498,962.13$525.09T$24.42M
2017-12-3128,661,955.24$1006.41T$35.11M
2017-09-3033,099,265.44$1440.35T$43.52M
2017-06-3028,879,915.58$1450.38T$50.22M
2017-03-3127,335,238.77$1559.97T$57.07M
2016-12-3120,083,242.66$1291.45T$64.31M

Annual Price/Book Ratio

DatePrice/Book RatioMarket capitalizationShareholder equity
2025-09-305.48$13.87M$2.53M
2024-09-30267.76$398.15M$1.49M
2023-12-3188.01$586.43M$6.66M
2022-12-315,544.2$20.3B$3.66M
2021-12-313,825.92$169.62B$44.33M
2020-12-31314,022.65$4.55T$14.49M
2019-12-31529,636.09$12.77T$24.11M
2018-12-313,230,728.31$42.35T$13.11M
2017-12-3128,661,955.24$1006.41T$35.11M
2016-12-3120,083,242.66$1291.45T$64.31M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36